心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

冠状动脉血栓抽吸临床应用专家共识

2017-06-06 中国医师协会心血管内科医师分会 中华医学杂志.2017,97(21):1624-1632.

冠状动脉血栓抽吸

随着直接PCI的广泛开展，由冠状动脉血栓导致的微循环栓塞等问题日渐突出，血栓抽吸和栓塞防护装置由此应运而生。早在20世纪80年代，就有血栓抽吸装置用于处理冠状动脉血栓的个案报道。2002年，第一项评价机械抽吸导管用于急性冠脉综合征（ACS）的随机对照试验发表。2003年，美国FDA批准第一款带有远段封堵球囊的手动血栓抽吸装置2005年，第一项在急性ST段抬高型心肌梗死（直接PCI时使用手动抽吸导管

中文标题：

冠状动脉血栓抽吸临床应用专家共识

发布机构：

中国医师协会心血管内科医师分会

发布日期：

2017-06-06

简要介绍：

随着直接PCI的广泛开展，由冠状动脉血栓导致的微循环栓塞等问题日渐突出，血栓抽吸和栓塞防护装置由此应运而生。早在20世纪80年代，就有血栓抽吸装置用于处理冠状动脉血栓的个案报道。2002年，第一项评价机械抽吸导管用于急性冠脉综合征（ACS）的随机对照试验发表。2003年，美国FDA批准第一款带有远段封堵球囊的手动血栓抽吸装置2005年，第一项在急性ST段抬高型心肌梗死（直接PCI时使用手动抽吸导管的随机对照试验发表2008年发布的TAPAS试验进一步推动了血栓抽吸的临床应用与研究进程[然而，近年发表的TASTE试验和TOTAL试验却使血栓抽吸的疗效与安全性面临质疑。目前，冠状动脉血栓抽吸在临床上存在较多争议与困惑，亟需统一认识，规范技术操作，指导合理应用，进而提高AMI介入治疗的水平。

 

拓展指南：与冠状动脉相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=冠状动脉血栓抽吸临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=92f571c001a8e383, title=冠状动脉血栓抽吸临床应用专家共识, enTitle=, guiderFrom=中华医学杂志.2017,97(21):1624-1632., authorId=null, author=, summary=随着直接PCI的广泛开展，由冠状动脉血栓导致的微循环栓塞等问题日渐突出，血栓抽吸和栓塞防护装置由此应运而生。早在20世纪80年代，就有血栓抽吸装置用于处理冠状动脉血栓的个案报道。2002年，第一项评价机械抽吸导管用于急性冠脉综合征（ACS）的随机对照试验发表。2003年，美国FDA批准第一款带有远段封堵球囊的手动血栓抽吸装置2005年，第一项在急性ST段抬高型心肌梗死（直接PCI时使用手动抽吸导管, cover=, journalId=null, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jun 06 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>随着直接PCI的广泛开展，由冠状动脉血栓导致的微循环栓塞等问题日渐突出，血栓抽吸和栓塞防护装置由此应运而生。早在20世纪80年代，就有血栓抽吸装置用于处理冠状动脉血栓的个案报道。2002年，第一项评价机械抽吸导管用于急性冠脉综合征（ACS）的随机对照试验发表。2003年，美国FDA批准第一款带有远段封堵球囊的手动血栓抽吸装置2005年，第一项在急性ST段抬高型心肌梗死（直接PCI时使用手动抽吸导管的随机对照试验发表2008年发布的TAPAS试验进一步推动了血栓抽吸的临床应用与研究进程[然而，近年发表的TASTE试验和TOTAL试验却使血栓抽吸的疗效与安全性面临质疑。目前，冠状动脉血栓抽吸在临床上存在较多争议与困惑，亟需统一认识，规范技术操作，指导合理应用，进而提高AMI介入治疗的水平。 </P> <P> </P>拓展指南：<strong>与<font color=red>冠状动脉</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=1331a1c001a85250" title="2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性" target=_blank>2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=261ce1c001ae44c6" title="急性冠状动脉综合征患者检测心肌肌钙蛋白的专家共识" target=_blank>急性冠状动脉综合征患者检测心肌肌钙蛋白的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9585b1c001a3997c" title="冠状动脉微血管疾病诊断和治疗的中国专家共识" target=_blank>冠状动脉微血管疾病诊断和治疗的中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=167041c001a31829" title="中西医结合冠状动脉旁路移植术Ⅰ期心脏康复专家共识" target=_blank>中西医结合冠状动脉旁路移植术Ⅰ期心脏康复专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=15a061c001a2380a" title="2017NICE指南：心脏CT是冠状动脉疾病的最佳检验方法" target=_blank>2017NICE指南：心脏CT是冠状动脉疾病的最佳检验方法</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89" target=_blank>有关冠状动脉更多指南</a></ul>, tagList=[TagDto(tagId=57458, tagName=冠状动脉血栓抽吸)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9761, appHits=228, showAppHits=0, pcHits=7921, showPcHits=2592, likes=141, shares=7, comments=6, approvalStatus=1, publishedTime=Fri Aug 25 20:02:27 CST 2017, publishedTimeString=2017-06-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 25 20:02:27 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:36:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=冠状动脉血栓抽吸临床应用专家共识)])
冠状动脉血栓抽吸临床应用专家共识
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=294127, encodeId=6e6229412ee1, content=pci, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Thu Mar 08 08:06:57 CST 2018, time=2018-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243110, encodeId=4a6b24311025, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Tue Sep 12 07:46:41 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238862, encodeId=0428238862c5, content=学习一下!谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Aug 31 06:36:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238741, encodeId=8c51238e41a6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Aug 30 18:51:19 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237621, encodeId=05b923e6210f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 27 09:09:30 CST 2017, time=2017-08-27, status=1, ipAttribution=)]
    2018-03-08 1881ff5116m

    pci

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=294127, encodeId=6e6229412ee1, content=pci, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Thu Mar 08 08:06:57 CST 2018, time=2018-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243110, encodeId=4a6b24311025, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Tue Sep 12 07:46:41 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238862, encodeId=0428238862c5, content=学习一下!谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Aug 31 06:36:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238741, encodeId=8c51238e41a6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Aug 30 18:51:19 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237621, encodeId=05b923e6210f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 27 09:09:30 CST 2017, time=2017-08-27, status=1, ipAttribution=)]
    2017-09-12 1881ff5116m

    厉害

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=294127, encodeId=6e6229412ee1, content=pci, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Thu Mar 08 08:06:57 CST 2018, time=2018-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243110, encodeId=4a6b24311025, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Tue Sep 12 07:46:41 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238862, encodeId=0428238862c5, content=学习一下!谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Aug 31 06:36:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238741, encodeId=8c51238e41a6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Aug 30 18:51:19 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237621, encodeId=05b923e6210f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 27 09:09:30 CST 2017, time=2017-08-27, status=1, ipAttribution=)]
    2017-08-31 ren1mw

    学习一下!谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=294127, encodeId=6e6229412ee1, content=pci, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Thu Mar 08 08:06:57 CST 2018, time=2018-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243110, encodeId=4a6b24311025, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Tue Sep 12 07:46:41 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238862, encodeId=0428238862c5, content=学习一下!谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Aug 31 06:36:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238741, encodeId=8c51238e41a6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Aug 30 18:51:19 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237621, encodeId=05b923e6210f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 27 09:09:30 CST 2017, time=2017-08-27, status=1, ipAttribution=)]
    2017-08-30 1e0ece0dm09(暂无匿称)

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=294127, encodeId=6e6229412ee1, content=pci, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Thu Mar 08 08:06:57 CST 2018, time=2018-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243110, encodeId=4a6b24311025, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d502143137, createdName=1881ff5116m, createdTime=Tue Sep 12 07:46:41 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238862, encodeId=0428238862c5, content=学习一下!谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Aug 31 06:36:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238741, encodeId=8c51238e41a6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Aug 30 18:51:19 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237621, encodeId=05b923e6210f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 27 09:09:30 CST 2017, time=2017-08-27, status=1, ipAttribution=)]
    2017-08-27 Y—xianghai

    学习了新知识

    0